☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
P-II
Neurocrine Biosciences Reports Positive Results from P-II study of NBI-1065845 in MDD
April 24, 2024
Hepion Pharmaceuticals Begins Wind-Down Activities in ASCEND-NASH P-IIb Study
April 22, 2024
Sanofi to Highlight New Data from the P-II Study of Frexalimab for the Treatment of Multiple Sclerosis at AAN 2024
April 17, 2024
Corcept Concludes Patient Recruitment in the P-II Study of Dazucorilant for Amyotrophic Lateral Sclerosis (ALS)
April 16, 2024
The US FDA Grants Orphan Drug Designation to Candel Therapeutics’ CAN-2409 as a Treatment for Pancreatic Cancer
April 12, 2024
Vertex to Acquire Alpine Immune Sciences for ~$4.9B
April 11, 2024
Load more...
Back to Home